Sweden With almost three decades of experience in the Swedish life science industry, Jan Hellqvist, general manager of KLIFO in Sweden, explains why the country has seen the number of clinical studies from small and medium size companies skyrocket in recent years. Moreover, he discusses the possibilities of opening KLIFO’s affiliate…
Sweden TFS is a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies. Headquartered in Lund, TFS serves global clinical trial markets with local expertise and worldwide project delivery. János Filakovský, MD, Ph.d. MBA, CEO of TFS, discusses the company’s unique capabilities and analyzes the Swedish life sciences industry’s potential…
China John Moller, CEO; and Yooni Kim, executive director of Asia operations, for Novotech, share the competitive positioning of Novotech as a full-service CRO for biotech companies interested in the Asia-Pacific region; the solutions and services they offer, including their clinical development consultancy, ‘BioDesk’; as well as the exciting opportunities they…
China Dr Cheney Mao, chairman and CEO of Viva Biotech, shares the extremely unique business model of the company, which started as a highly specialized CRO in 2008, before launching a new ‘equity-for-service’ model in 2016 that focused on incubating biotech start-ups from their inception to IND stage. He highlights their…
Sweden IQVIA is a leading global provider of information, innovative technology solutions and contract research services for the healthcare industry. Stefan Ohlsson, general manager at IQVIA Nordics, discusses how Sweden’s unique quality registries can be further improved, the company’s ability to help clients at any stage of development, and how IQVIA…
Pharma Market Poland is by far the largest pharma market in the Central and Eastern Europe (CEE) region, with a total value of EUR 6.352 billion for 2017. The Czech Republic is in second place, followed by Romania and Hungary Made with Visme Infographic Maker The CEE countries that exported…
China Dr. Zhengyu Yuan, president & CEO of MicuRx, shares the story of how MicuRx was founded in 2007 to develop new and innovative antimicrobial drugs; their flagship product, contezolid, which recently concluded Phase III trials in China; and their future plans for an IPO. We combined US experience and…
Taiwan Susan Hsu, managing director of Taiwanese data-driven CRO StatPlus, speaks about the key trends impacting Taiwan’s clinical trial environment and goes on to share her views on the increasing attractiveness of the island. Hsu concludes by explaining the service provider’s strategic position within APAC and its unique strength as a…
CRO Katie Lai, associate director of Medpace Taiwan, introduces the company’s history in Taiwan and highlights the CRO’s unique service offering as a partner of choice to the biotech sector. Lai goes on to give her expert insights in the evolving clinical research environment of Taiwan and the APAC region. …
Taiwan Betty Li, managing director of PPC, a well-positioned leader in the APAC CRO landscape, speaks about the strategic significance of the group’s Taiwan affiliate and goes on to share her views on Taiwan’s increasingly attractive clinical trial landscape. Li concludes by explaining how Taiwan and PPC can be a top…
Taiwan Dr. Wen-cherng Tsai, founder and chairman of SuperLab, explains the company’s unique business model as the only third-party fair testing organization and pre-clinical CRO across the medical, chemical and biological related fields. Dr. Tsai goes on to highlight SuperLab’s competitive offering and top-tier accreditation as a premier service partner in…
Spain Through a merger between INC Research and inVentiv Health in 2018, Syneos Health has become the industry’s only fully integrated biopharmaceutical solutions organisation which includes one of the world’s top three global clinical research organisations (CRO) and a contract commercial organisation (CCO). Rosa Gonzalez Galindo explains the scale and scope…
See our Cookie Privacy Policy Here